Last reviewed · How we verify
NCT07021924
The Effect of Fu's Subcutaneous Needling on Skin Temperature in Healthy Subjects
NA trial testing Fu's subcutaneous needling in Skin Temperature Change in 60 participants. Not yet recruiting.
1 July 2025
Quick facts
| Lead sponsor | China Medical University Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 July 2025 |
| Primary completion | 1 July 2025 |
| Estimated completion | 1 May 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Fu's subcutaneous needling
- Acupuncture — full drug profile →
Conditions studied
- Skin Temperature Change — all drugs for Skin Temperature Change →
Sponsor
China Medical University Hospital
Who can join
18 and older, any sex, with Skin Temperature Change. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to investigate whether there are differences in skin temperature at local or distal sites following Fu's Subcutaneous Needling (FSN) treatment or acupuncture treatment, and compare the extent to which FSN or acupuncture induces an increase in skin temperature in healthy population. The main questions it aims to answer are: 1. Fu's Subcutaneous Needling (FSN) treatment increases local blood perfusion, thereby elevating skin temperature. 2. The ability of FSN treatment to increase skin temperature is not inferior to that of acupuncture and may, in fact, be superior. Researchers will compare the skin temperature changes among three groups which are FSN, acupuncture and control group to see if there are statistically significantly changes . Participants will enroll into three groups which are FSN, acupuncture and no any intervention respectively.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07021924
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fu's subcutaneous needling
Trials testing the same drug.
- NCT03605576 — Remote Fu's Subcutaneous Needling for Patients With Chronic Neck Pain · NA · unknown
- NCT03605563 — Fu's Subcutaneous Needling on the Myofascial Trigger Points: Lateral Epicondylitis · NA · unknown
Other China Medical University Hospital trials
Trials by the same sponsor.
- NCT07525700 — The Effects of Combining Electronic Picture Books With RPG-Based Gamified Learning on Nursing Students' Motivation and L · NA · not yet recruiting
- NCT07463391 — Chinese Classics Recitation Training in Subjective Cognitive Decline · NA · not yet recruiting
- NCT07482189 — Effectiveness and Efficiency of an Upper Limb Active-Passive Exoskeleton Robot in Patients With Frozen Shoulder · NA · not yet recruiting
- NCT07437144 — Exploring the Effects of Shangshou Daoyin Method on Improving Sleep Quality, Quality of Life, and TCM Constitution in Br · NA · not yet recruiting
- NCT07232667 — Digital Technology for Active and Healthy Ageing in Taiwan · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07021924 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by China Medical University Hospital
- Last refreshed: 15 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07021924.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing